Haemostasis

Surgery

Volumn 28, Issue 11, 2010, Pages 530-535

  Batty, Paul ^a   Smith, J Graham ^b,c  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c FRIMLEY PARK HOSPITAL   (United Kingdom)

Author keywords

Bleeding history; cell based model; endothelial cell; fibrinolysis; haemostasis; platelet; protein C; tissue factor; von Willebrand factor

Indexed keywords

ADRENALIN; ALPHA 2 ANTIPLASMIN; ANTITHROMBIN; FATTY ACID BINDING PROTEIN; FIBRINOGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; HEPARIN COFACTOR II; HISTAMINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEINASE INHIBITOR; THROMBIN; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VERY LATE ACTIVATION ANTIGEN 2; VON WILLEBRAND FACTOR;

BLEEDING; BLEEDING DISORDER; BLEEDING TIME; BLOOD VESSEL INJURY; FIBRINOLYSIS; HEMOSTASIS; INTERNATIONAL NORMALIZED RATIO; PARTIAL THROMBOPLASTIN TIME; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTHROMBIN TIME; REGULATORY MECHANISM; SCREENING TEST; SHORT SURVEY; SURGICAL PATIENT; THROMBOCYTE; THROMBOGENESIS; VASCULAR ENDOTHELIUM; VEIN OCCLUSION;

EID: 78049235677     PISSN: 02639319     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpsur.2010.08.008     Document Type: Review

References (16)

1. A.V. Hoffbrand, D. Catovsky, and E.G.D. Tuddenham Postgraduate haematology 5th edn. 2005 Blackwell Publishing
2. D. O'Shaughnessy, M. Makris, and D. Lilllicrap Practical hemostasis and thrombosis 1st edn. 2005 Blackwell Publishing
3. M. Hoffman, and D.M. Monroe A cell based model of hemostasis Thromb Haemost 85 2001 958 965
4. D.M. Monroe, and M. Hoffman What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 26 2006 41 48
5. J.C. Rau, L.M. Beaulieu, J.A. Huntington, and F.C. Church Serpins in thrombosis, hemostasis and fibrinolysis J Thromb Haemost 5 S1 2007 102 115
6. E. Abraham, K. Reinhart, and S. Opal Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis JAMA 290 2003 238 247
7. P.P. Sarangi, H.-w. Lee, and M. Kim Activated protein C action in inflammation Br J Haematol 148 2009 817 833
8. G.R. Bernard, J.-L. Vincent, and P.-F. Laterre Efficacy and safety of recombinant human activated protein c for severe sepsis N Engl J Med 344 2001 699 709
9. M. Levi, C.H. Toh, J. Thachil, and H.G. Watson Guidelines for the diagnosis and management of disseminated intravascular coagulation Br J Haematol 145 2009 24 33
10. G. Cesarman-Maus, and K.A. Hajjar Molecular mechanisms of fibrinolysis Br J Haematol 129 2005 307 321
11. Website: Practical Hemostasis http://www.practical-hemostasis.com
12. Y.L. Chee, J.C. Crawford, H.G. Watson, and M. Greaves Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures Br J Haematol 140 2008 496 504
13. Preoperative tests. The use of routine preoperative tests for elective surgery Clinical Guideline 3 2003 National Institute for Clinical Excellence pp. 1-117
14. A. Tosetto, F. Rodeghiero, and G. Castaman A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD) J Thromb Haemost 4 2006 766 773
15. P. Batty, and J.G. Smith Anticoagulation Surgery 28 2010 243 247
16. C. Ebdon, P. Batty, and J.G. Smith Haematopoiesis and red blood cells Surgery 28 2010 248 253